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INTRODUCTION
Brazilian spotted fever (BSF) is an acute febrile
tick-borne disease caused by Rickettsia rickettsii.
First described in 1929, initially it was seen as an
adult disease. Since its re-emergence in 1985, the
expansion of transmission to peri-urban areas has
brought children into contact with the main tick
vector, Amblyomma cajennense.
In general, it has two distinct clinical phases. In
the early stage there is a non-speciﬁc febrile
syndrome, with headache, myalgia, nausea, vom-
iting and abdominal pain, followed by a maculo-
papular exanthem in almost 50% of patients.
Around day 6 of symptoms, a petechial exan-
them, haemodynamic instability, respiratory
distress and neurological disorders deﬁne a
life-threatening disease, usually associated with
multi-organ failure and a high case-fatality.
For this reason, early clinical suspicion and
treatment are necessary to reduce morbidity and
mortality. The increasing number of infected
children, especially after the re-emergence of
BSF since 1985, is of particular concern.
We describe the main clinical and epidemiolo-
gical aspects of BSF in the paediatric age-segment.
PATIENTS AND METHODS
Retrospective analysis of surveillance records kept by the State
Health Department of Sa˜o Paulo state, southeastern Brazil, was
carried out. The population studied was BSF conﬁrmed cases
(by indirect immunoﬂuoresence assay in serum, Rickettsia
isolation in cell culture, and ⁄ or immunohistochemistry) aged
0–17 years old, between 2003 and 2006.
RESULTS
A total of 5949 BSF suspected cases were notiﬁed
during the period, and 206 were conﬁrmed. In the
0–17 years old segment, there were 2476 sus-
pected cases and 60 BSF conﬁrmed or compatible
cases (44 were conﬁrmed by laboratory tests,
three conﬁrmed by clinical-epidemiological crite-
ria, and 13 presented with clinical signs compa-
tible with BSF and a positive IFA, however
without four-fold increased titres). The median
age was 9 years (range 1–16 years) and 60% were
male. Of 44 BSF laboratorial-conﬁrmed patients,
in 81.8% the conﬁrmation was made by four-fold
increased titres in paired serum samples by IFA,
in four patients (9.1%) by Rickettsia isolation,
and in four (9.1%) by immunohistochemical
analysis of post-mortem tissues.
Rickettsia exposure was probably as a result
of: tick exposure (51.7%), tick exposure and
contact with animals (areas with horses, capy-
baras and ⁄ or dogs) (21.7%), contact with animals
(6.7%), contact with vegetation (rural, forest
and ⁄ or waterside areas) (3.3%). In 16.7% a risk
factor for infection could not be identiﬁed.
Clinically, non-speciﬁc symptoms included: fever
(90%), headache (91.7%), myalgia (85%), pros-
tration (56.7%), abdominal pain (45%), nausea
and ⁄ or vomiting (45%), exanthem (40%), diar-
rhoea (21.7%), conjunctival hyperaemia (21.7%),
hepato- and splenomegaly (13.3%), and lymph-
adenopathy (8.3%). Severe manifestations, usu-
ally associated with a more severe disease, were
also observed in a high proportion: icterus
(13.3%), petechiae and ⁄ or haemorrhagic suffu-
sions (40%), other haemorrhagic manifestations
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(26.7%), hypotension and ⁄ or shock (18.3%),
neurological manifestations (coma, 10%; convul-
sions, 5%), respiratory distress (8.3%), and acute
renal failure (6.7%). The case–fatality proportion
was 28.4%.
DISCUSSION
Almost one-third of all conﬁrmed cases in the
state of Sa˜o Paulo belong to the paediatric age
segment. Despite a lower case-fatality observed in
this age-speciﬁc group when compared with the
general population (30% compared with 41.9%)
[1], BSF remains a health problem in Brazil.
The risk of transmission was associated with
rural and water-side areas, with frequent pres-
ence of animals such as horses, dogs and capy-
baras. These risk factors were previously reported
in other case-series [2].
In the early stage, BSF is a differential diagnosis
of exanthematic febrile syndrome, but the rapid
progression to a life-threatening disease is usual.
In this case-series exanthem was observed in
less than 50% of patients, much less than
observed among Rocky Mountain spotted fever
(RMSF) patients [3].
One possible explanation could be an incorrect
inclusion of data in notiﬁcation ﬁles. Another
cause to be postulated is the misperception of
exanthem in dark skin patients, who make up a
signiﬁcant percentage of the population in Brazil.
The low frequency of exanthem was also ob-
served previously, including in a case-series of
hospitalised BSF patients [1].
As mentioned previously, BSF seems to be a
more severe disease when compared with RMSF
[1]. Possible causes of this observation are the late
diagnosis with consequent delay in speciﬁc ther-
apy introduction, and the use of chloramphenicol
as the only drug for parenteral use in severe cases,
despite much epidemiological and in vitro
evidence for the superiority of tetracyclines for
R. rickettsii treatment [4]. Another explanation for
the higher BSF morbidity and mortality that must
be considered is the possible higher virulence of
R. rickettsii in Brazil.
In Brazil, the frequent association of fever,
shock and petechiae ⁄haemorrhagic suffusions
(Fig. 1), makes BSF an important differential
diagnosis of other acute purpuras, with special
attention to meningococcal disease.
For this reason, the improving early suspicion
and the recommendation of early introduction of
speciﬁc treatment should be a priority, in all ages,
even when tick exposure has not been reported or
exanthem is absent.
In Brazil, chloramphenicol remains the ﬁrst
choice for treatment of BSF in the paediatric age-
segment. Because of the possible association
between its use and a higher risk of R. rickettsii-
relateddeaths, the recommendationofdoxycycline
should be underscored in all BSF suspected cases.
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Fig. 1. Petechial exanthema in a
severe case of BSF in a child
(Author: Angerami, RN).
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